Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | ATP2A2 |
| Upstream (Parents) |
|---|
| (<<) CCND1 → ATP2A2 |
| (<<) E2F7 → ATP2A2 |
| (<<) HGS → ATP2A2 |
| (<<) LIG1 → ATP2A2 |
| (<<) MESDC1 → ATP2A2 |
| (<<) PKM2 → ATP2A2 |
| (<<) RPL35A → ATP2A2 |
| (<<) SPAG5 → ATP2A2 |
| (<<) TUBA1B → ATP2A2 |
| (<<) TUBA1C → ATP2A2 |
| Downstream (Children) |
|---|
| ATP2A2 → CSNK1D (>>) |
| ATP2A2 → DDR1 (>>) |
| ATP2A2 → FZD8 (>>) |
| ATP2A2 → ITPR2 (>>) |
| ATP2A2 → KPNA1 (>>) |
| ATP2A2 → MAPK8 (>>) |
| ATP2A2 → MAPKAPK5 (>>) |
| ATP2A2 → NRIP3 (>>) |
| ATP2A2 → PDIA4 (>>) |
| ATP2A2 → PLK3 (>>) |
| ATP2A2 → RNASE4 (>>) |
| ATP2A2 → SLC7A5 (>>) |
| ATP2A2 → TFF1 (>>) |
| ATP2A2 → TNC (>>) |
| ATP2A2 → VPS37B (>>) |
| ATP2A2 → WDR36 (>>) |
